IRIS Accounts Production v25.1.4.42 12196453 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh121964532023-09-30121964532024-09-30121964532023-10-012024-09-30121964532022-09-30121964532022-10-012023-09-30121964532023-09-3012196453ns15:EnglandWales2023-10-012024-09-3012196453ns14:PoundSterling2023-10-012024-09-3012196453ns10:Director12023-10-012024-09-3012196453ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3012196453ns10:SmallEntities2023-10-012024-09-3012196453ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3012196453ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3012196453ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3012196453ns10:FullAccounts2023-10-012024-09-3012196453ns10:Director22023-10-012024-09-3012196453ns10:CompanySecretary12023-10-012024-09-3012196453ns10:RegisteredOffice2023-10-012024-09-3012196453ns5:CurrentFinancialInstruments2024-09-3012196453ns5:CurrentFinancialInstruments2023-09-3012196453ns5:ShareCapital2024-09-3012196453ns5:ShareCapital2023-09-3012196453ns5:RetainedEarningsAccumulatedLosses2024-09-3012196453ns5:RetainedEarningsAccumulatedLosses2023-09-3012196453ns5:FurnitureFittings2023-10-012024-09-3012196453ns5:ComputerEquipment2023-10-012024-09-3012196453ns5:PlantMachinery2023-09-3012196453ns5:PlantMachinery2023-10-012024-09-3012196453ns5:PlantMachinery2024-09-3012196453ns5:PlantMachinery2023-09-3012196453ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-10-012024-09-3012196453ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-09-3012196453ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3012196453ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30121964531ns10:Director12023-09-30121964531ns10:Director12022-09-30121964531ns10:Director12023-10-012024-09-30121964531ns10:Director12022-10-012023-09-30121964531ns10:Director12024-09-30121964531ns10:Director12023-09-3012196453ns10:Director222023-09-3012196453ns10:Director222022-09-3012196453ns10:Director222023-10-012024-09-3012196453ns10:Director222022-10-012023-09-3012196453ns10:Director222024-09-3012196453ns10:Director222023-09-30
REGISTERED NUMBER: 12196453 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2024

for

Clp Medical Limited

Clp Medical Limited (Registered number: 12196453)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Clp Medical Limited

Company Information
for the Year Ended 30 September 2024







DIRECTORS: Mr R Potter
Mrs C Potter





SECRETARY: Mrs C Potter





REGISTERED OFFICE: 128 City Road
London
EC1V 2NX





REGISTERED NUMBER: 12196453 (England and Wales)





ACCOUNTANTS: Wilson Partners Limited
Chartered Accountants
TOR
Saint-Cloud Way
Maidenhead
Berkshire
SL6 8BN

Clp Medical Limited (Registered number: 12196453)

Balance Sheet
30 September 2024

30.9.24 30.9.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 5,082 6,092

CURRENT ASSETS
Debtors 5 99,771 52,686
Cash at bank 42,523 59,444
142,294 112,130
CREDITORS
Amounts falling due within one year 6 (110,851 ) (59,638 )
NET CURRENT ASSETS 31,443 52,492
TOTAL ASSETS LESS CURRENT LIABILITIES 36,525 58,584

PROVISIONS FOR LIABILITIES (1,263 ) (1,523 )
NET ASSETS 35,262 57,061

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 35,162 56,961
35,262 57,061

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 June 2025 and were signed on its behalf by:




Mr R Potter - Director


Clp Medical Limited (Registered number: 12196453)

Notes to the Financial Statements
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

Clp Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In the application of the company's accounting policies the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

The company does not make significant estimates and assumptions concerning the future.

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for the provision of services in the ordinary nature of the business. Turnover is shown net of Value Added Tax as calculated under the Flat Rate Scheme.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Fixtures and fittings - 25% on cost
Computer equipment - 33% on cost

Tangible fixed assets are included at cost less depreciation and impairment.

Financial instruments
Basic financial instruments are recognised at amortised cost using the effective interest method, except for investments in non-convertible preference and non-puttable preference and ordinary shares, which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and therefore at fair value, with changes recognised in profit and loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Clp Medical Limited (Registered number: 12196453)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023 12,676
Additions 2,563
Disposals (2,107 )
At 30 September 2024 13,132
DEPRECIATION
At 1 October 2023 6,420
Charge for year 3,043
Eliminated on disposal (1,413 )
At 30 September 2024 8,050
NET BOOK VALUE
At 30 September 2024 5,082
At 30 September 2023 6,256

Clp Medical Limited (Registered number: 12196453)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
Additions 999
At 30 September 2024 999
DEPRECIATION
Charge for year 165
At 30 September 2024 165
NET BOOK VALUE
At 30 September 2024 834

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 79,499 23,795
Other debtors 20,272 28,891
99,771 52,686

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Hire purchase contracts 707 -
Trade creditors 2,780 1,764
Taxation and social security 92,466 57,802
Other creditors 14,898 72
110,851 59,638

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 September 2024 and 30 September 2023:

30.9.24 30.9.23
£    £   
Mr R Potter
Balance outstanding at start of year 4,611 -
Amounts advanced 13,372 16,952
Amounts repaid (17,983 ) (12,341 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 4,611

Clp Medical Limited (Registered number: 12196453)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

Mrs C Potter
Balance outstanding at start of year 2,886 -
Amounts advanced - 14,980
Amounts repaid (16,734 ) (12,094 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (13,848 ) 2,886

8. ULTIMATE CONTROLLING PARTY

The is no ultimate controlling party.